MedTrace Logo

Family Connections Transdiagnostic for Relatives of People With Emotional Dysregulation

NCT07585955 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 172

Last updated 2026-05-28

No results posted yet for this study

Summary

The aim of this study is to evaluate the efficacy of the Family Connections Transdiagnostic (FC-T) program in relatives of individuals with psychological disorders associated with emotional dysregulation through a randomized controlled trial.

Conditions

  • Relatives

Interventions

BEHAVIORAL

Family Connections Transdiagnostic for relatives of people with emotional dysregulation

The intervention lasts 3 months and includes 12 two-hour sessions in a group format on a weekly basis. The FC-T program is divided into 6 modules: 2 modules of psychoeducation on emotional dysregulation (ED) and 4 modules of Dialectical Behavior Therapy (DBT)-based skills training (relationship mindfulness, emotional regulation, acceptance, validation, and problem management).

BEHAVIORAL

Optimized Treatment as Usual (TAU-O)

Family members will receive the usual care available in their clinical setting. In addition, they will participate in a single 3-hour group psychoeducation session including the following components: (1) up-to-date information and research on emotional dysregulation (epidemiology, frequency, comorbidity, risk and protective factors); and (2) psychoeducation on the development of emotional dysregulation, explanatory models, and available treatments.

Sponsors & Collaborators

  • University of Valencia

    lead OTHER

Principal Investigators

  • Laura Díaz-Sanahuja, Dr. Professor · University of Valencia

  • Cayetana Garoz, PhD · University of Castellón

  • Álvaro Cadiñanos, PhD · University of Valencia

  • Elena González-Perpiñá, PhD · University of Valencia

  • Antonio Arnal, PhD · University of Valencia

  • Ginnette Muñoz, PhD · University of Valencia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-03
Primary Completion
2026-12-25
Completion
2027-12-25

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07585955 on ClinicalTrials.gov